A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia

Cancer Causes and Control

Volumn 23, Issue 11, 2012, Pages 1797-1803

  Lupo, Philip J ^a   Nousome, Darryl ^a   Kamdar, Kala Y ^b   Okcu, M Fatih ^b   Scheurer, Michael E ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukemia; Case parent triad; Folate; Genetic epidemiology; Pediatric cancer

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE REDUCTASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE HOMOCYSTEINE METHYLTRANSFERASE; DIHYDROFOLATE REDUCTASE; DNA; METHYLTRANSFERASE; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FAMILY STUDY; FEMALE; FOLATE METABOLISM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; INFANT; LOGLINEAR MODEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MOTHER; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGENY; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; UTERUS;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84867992504     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0058-z     Document Type: Article

References (33)

1. Margolin JF, Rabin KR, Steuber CP, Poplack DG (2011) Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams & Wilkins, Philadelphia, pp 518-565
2. Surveillance Epidemiology and End Results (2011) Childhood Cancer. http://seer.cancer.gov/csr/1975-2008/results-merged/sect-28-childhood-cancer. pdf. Accessed 22 Jan 2012
3. Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354(2):166-178. doi:10.1056/NEJMra 052603 (Pubitemid 43076714)
4. Bas Suarez MP, Lopez Brito J, Santana Reyes C, Gresa Munoz M, Diaz Pulido R, Lodos Rojas JC (2011) Congenital acute lymphoblastic leukemia: a two-case report and a review of the literature. Eur J Pediatr 170(4):531-534. doi:10.1007/s00431-010-1339-8
5. Sherborne AL, Hemminki K, Kumar R, Bartram CR, Stanulla M, Schrappe M, Petridou E, Semsei AF, Szalai C, Sinnett D, Krajinovic M, Healy J, Lanciotti M, Dufour C, Indaco S, El-Ghouroury EA, Sawangpanich R, Hongeng S, Pakakasama S, Gonzalez-Neira A, Ugarte EL, Leal VP, Espinoza JP, Kamel AM, Ebid GT, Radwan ER, Yalin S, Yalin E, Berkoz M, Simpson J, Roman E, Lightfoot T, Hosking FJ, Vijayakrishnan J, Greaves M, Houlston RS (2011) Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica 96(7):1049-1054. doi: 10.3324/haematol. 2011.040121
6. Vijayakrishnan J, Houlston RS (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 95(8):1405-1414. doi:10.3324/haematol.2010.022095
7. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, Houlston RS (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41(9):1006-1010. doi:10.1038/ng.430
8. Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, Gast A, Dobbins SE, Ma Y, Sheridan E, Taylor M, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Moorman AV, Harrison CJ, Tomlinson IP, Richards S, Zimmermann M, Szalai C, Semsei AF, Erdelyi DJ, Krajinovic M, Sinnett D, Healy J, Gonzalez Neira A, Kawamata N, Ogawa S, Koeffler HP, Hemminki K, Greaves M, Houlston RS (2010) Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 42(6):492-494. doi:10.1038/ng.585
9. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC, Pui CH, Evans WE, Relling MV (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nature Genet 41(9):1001-1005. doi:10.1038/ng.432
10. Koppen IJ, Hermans FJ, Kaspers GJ (2010) Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 148(1):3-14. doi: 10.1111/j.1365-2141.2009.07898.x
11. Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, Okcu MF (2012) A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 58(4):513-518. doi:10.1002/pbc.23137
12. Metayer C, Scelo G, Chokkalingam AP, Barcellos LF, Aldrich MC, Chang JS, Guha N, Urayama KY, Hansen HM, Block G, Kiley V, Wiencke JK, Wiemels JL, Buffler PA (2011) Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 22(9):1243-1258. doi:10.1007/s10552-011-9795-7
13. Lightfoot TJ, Johnston WT, Painter D, Simpson J, Roman E, Skibola CF, Smith MT, Allan JM, Taylor GM (2010) Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood 115(19):3923-3929. doi:10.1182/blood-2009-10-249722
14. Infante-Rivard C, Vermunt JK, Weinberg CR (2007) Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. Am J Epidemiol 165(11):1248-1254 (Pubitemid 47234330)
15. Weinberg CR, Wilcox AJ, Lie RT (1998) A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62(4):969-978. doi:10.1086/301802 (Pubitemid 28194340)
16. Weinberg CR (1999) Allowing for missing parents in genetic studies of case-parent triads. Am J Hum Genet 64(4):1186-1193 (Pubitemid 30463050)
17. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of singlenucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74(1):106-120. doi:10.1086/381000 (Pubitemid 38085242)
18. National Heart L, and Blood Institute (2010) GVS: genome variation server version 5.11. http://gvs.gs.washington.edu/GVS/. Accessed 24 Jan 2012
19. Salanti G, Southam L, Altshuler D, Ardlie K, Barroso I, Boehnke M, Cornelis MC, Frayling TM, Grallert H, Grarup N, Groop L, Hansen T, Hattersley AT, Hu FB, Hveem K, Illig T, Kuusisto J, Laakso M, Langenberg C, Lyssenko V, McCarthy MI, Morris A, Morris AD, Palmer CN, Payne F, Platou CG, Scott LJ, Voight BF, Wareham NJ, Zeggini E, Ioannidis JP (2009) Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol 170(5):537-545. doi:10.1093/aje/kwp145
20. Wilcox AJ, Weinberg CR, Lie RT (1998) Distinguishing the effects of maternal and offspring genes through studies of "caseparent triads". Am J Epidemiol 148(9):893-901 (Pubitemid 28484109)
21. Agopian AJ, Mitchell LE (2011) MI-GWAS: a SAS platform for the analysis of inherited and maternal genetic effects in genomewide association studies using log-linear models. BMC Bioinformatics 12:117. doi:10.1186/1471-2105-12-117
22. Vermunt J.K.,LEM: A General Program for the Analysis of Categorical Data.1997, http://spitswww.uvt.nl/vermunt/ Tilberg University Accessed 20 Aug 2012
23. Mitchell LE, Weinberg CR (2005) Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: the "pent" design. Am J Epidemiol 162(7):676-685. doi:10.1093/aje/kwi249 (Pubitemid 41437367)
24. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 57(1):289-300
25. Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D (2004) Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103(1):252-257. doi:10.1182/blood-2003-06-1794 (Pubitemid 38029946)
26. Mostowska A, Hozyasz KK, Biedziak B, Misiak J, Jagodzinski PP (2010) Polymorphisms located in the region containing BHMT and BHMT2 genes as maternal protective factors for orofacial clefts. Eur J Oral Sci 118(4):325-332. doi:10.1111/j.1600-0722.2010.00757.x
27. Oikawa S, Murakami K, Kawanishi S (2003) Oxidative damage to cellular and isolated DNA by homocysteine: implications for carcinogenesis. Oncogene 22(23):3530-3538. doi:10.1038/sj.onc. 1206440 (Pubitemid 36765312)
28. Martinez CA, Northrup H, Lin JI, Morrison AC, Fletcher JM, Tyerman GH, Au KS (2009) Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida. Am J Obstet Gynecol 201(4): 394.e1-11. doi:10.1016/j.ajog.2009.06.04
29. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94(7):3290-3295
30. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA, Morgan GJ (2002) Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99(10):3786-3791 (Pubitemid 34534552)
31. Canalle R, Silveira VS, Scrideli CA, Queiroz RG, Lopes LF, Tone LG (2011) Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymph 52(6):1118-1126. doi:10.3109/10428194.2011.559672
32. Goldmuntz E, Woyciechowski S, Renstrom D, Lupo PJ, Mitchell LE (2008) Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1(2): 126-132. doi:10.1161/CIRCGENETICS.108.796342
33. Lupo PJ, Mitchell LE, Goldmuntz E (2011) NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol 91(1):61-65. doi:10.1002/bdra.20745